← back to search

Emily J. Gallagher

IMEC · US
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Metabolism, Diabetes, and Cancer, Cancer Risks and Factors, Cancer, Lipids, and Metabolism, and Cancer Immunotherapy and Biomarkers.
h-index
42
citations
9,091
works
219
NIH funding
primary concept
Medicine
email

Recent publications

Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
npj Breast Cancer 2024cited by 30position: firstdoi
A high-throughput microfabricated platform for rapid quantification of metastatic potential
Science Advances 2024cited by 7position: middledoi
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design
PLoS ONE 2023cited by 56position: middledoi
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19
Annals of Internal Medicine 2021cited by 140position: middledoi
Kidney Recovery and Death in Critically Ill Patients With COVID-19–Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study
American Journal of Kidney Diseases 2021cited by 48position: middledoi
Association of Surge Conditions with Mortality Among Critically Ill Patients with COVID-19
Journal of Intensive Care Medicine 2021cited by 16position: middledoi
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
JAMA Internal Medicine 2020cited by 553position: middledoi
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States
American Journal of Kidney Diseases 2020cited by 234position: middledoi
Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool
Cell 2019cited by 437position: middledoi
Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality
Physiological Reviews 2015cited by 811position: firstdoi
The effect of dipeptidyl peptidase‐IV inhibition on bone in a mouse model of type 2 diabetes
Diabetes/Metabolism Research and Reviews 2013cited by 36position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Derek LeRoith · Icahn School of Medicine at Mount Sinai2 papers (2013–2015)Bernice Y. Kwong · Stanford University1 papers (2024–2024)Claudine Isaacs · Georgetown University1 papers (2024–2024) · 1 papers (2013–2013)Lee S. Schwartzberg · The University of Texas Health Science Center at Houston1 papers (2024–2024)Chad M. Hobson · Howard Hughes Medical Institute1 papers (2024–2024)Benjamin H. Kaffenberger · The Ohio State University1 papers (2024–2024)Dejan Juric · Harvard University1 papers (2024–2024) · 1 papers (2024–2024)Hui Sun · New York University1 papers (2013–2013)Smiti Bhattacharya · Columbia University1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024)Mario E. Lacouture · Island Hospital1 papers (2024–2024)James Hone · Columbia University1 papers (2024–2024)Shoshana Yakar · New York University1 papers (2013–2013)Marcus D. Goncalves · Cornell University1 papers (2024–2024)Michael S. Broder · Indiana University – Purdue University Indianapolis1 papers (2024–2024)Gabriel N. Hortobágyi · The University of Texas MD Anderson Cancer Center1 papers (2024–2024)Laura M. Spring · Harvard University1 papers (2024–2024)